Publication | Closed Access

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

VaccinationToll-like ReceptorsCross-protectionAutoimmune DiseaseRecombinant Fusion ProteinsVaccine TargetImmunologyToll-like ReceptorTherapeutic VaccineAutoimmunityHumoral ImmunityVaccine DesignPolyvalent VaccineMedicineVaccine Research